MedPath

Hydrocortisone succinate

Generic Name
Hydrocortisone succinate
Brand Names
Solu-cortef
Drug Type
Small Molecule
Chemical Formula
C25H34O8
CAS Number
2203-97-6
Unique Ingredient Identifier
IHV1VP592V

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

  • Acquired hemolytic anemias
  • Acute Gouty Arthritis
  • Ankylosing Spondylitis (AS)
  • Berylliosis
  • Bullous dermatitis herpetiformis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Dermatomyositis (DM)
  • Edema of the cerebrum
  • Hypercalcemia
  • Idiopathic Nephrotic Syndrome
  • Immune Thrombocytopenia (ITP)
  • Leukemias
  • Lymphoma
  • Mycosis Fungoides (MF)
  • Ocular Inflammatory Disease
  • Ophthalmia, Sympathetic
  • Pemphigus
  • Polymyositis
  • Primary adrenocortical insufficiency
  • Proteinuria
  • Psoriatic Arthritis
  • Pure Red Cell Aplasia
  • Regional Enteritis
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis, Juvenile
  • Secondary adrenocortical insufficiency
  • Secondary thrombocytopenia
  • Stevens-Johnson Syndrome
  • Systemic Lupus Erythematosus
  • Temporal Arteritis
  • Trichinosis
  • Tuberculous Meningitis
  • Ulcerative Colitis
  • Uveitis
  • Acute rheumatic carditis
  • Disseminated Pulmonary Tuberculosis (TB)
  • Exfoliative erythroderma
  • Fulminating Pulmonary Tuberculosis
  • Idiopathic eosinophilic pneumonias
  • Severe Allergic Reactions
  • Severe Erythema multiforme
  • Symptomatic Sarcoidosis

FDA Approved Products

Solu-Cortef
Manufacturer:Pharmacia & Upjohn Company LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:100 mg in 2 mL
Approved: 2024/01/04
NDC:0009-0011
Solu-Cortef
Manufacturer:Pharmacia & Upjohn Company LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:100 mg in 2 mL
Approved: 2024/01/04
NDC:0009-0825
Solu-Cortef
Manufacturer:Pharmacia & Upjohn Company LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:1000 mg in 8 mL
Approved: 2024/01/04
NDC:0009-0005
SOLU-CORTEF
Manufacturer:HF Acquisition Co. LLC, DBA HealthFirst
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:100 mg in 2 mL
Approved: 2024/02/22
NDC:51662-1261
Solu-Cortef
Manufacturer:Pharmacia & Upjohn Company LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:250 mg in 2 mL
Approved: 2024/01/04
NDC:0009-0013

Singapore Approved Products

SOLU-CORTEF FOR INJECTION 100 mg/vial
Manufacturer:PFIZER MANUFACTURING BELGIUM NV
Form:INJECTION, POWDER, FOR SOLUTION
Strength:100 mg/vial
Online:Yes
Approved: 1990/06/26
Approval:SIN04791P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath